Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study
{{output}}
Direct-to-consumer (DTC) pharmacogenomic (PGx) testing is expanding rapidly in the UK, yet no dedicated regulatory framework currently governs these services. Although a 2021 parliamentary inquiry recommended stronger safeguards and clearer technical standards... ...
